🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/02/2010 | 6,44 | 6,66 | 6,33 | 6,59 | +2,33% | 5,23% | 145.072 |
| 25/02/2010 | 6,70 | 6,70 | 6,33 | 6,44 | -1,71% | 5,59% | 86.642 |
| 24/02/2010 | 6,59 | 6,77 | 6,48 | 6,55 | -0,57% | 4,54% | 69.143 |
| 23/02/2010 | 6,59 | 6,70 | 6,44 | 6,59 | +0,00% | 3,98% | 173.578 |
| 22/02/2010 | 6,44 | 6,63 | 6,36 | 6,59 | +2,92% | 4,07% | 109.779 |
| 19/02/2010 | 6,33 | 6,59 | 6,29 | 6,40 | +3,01% | 4,73% | 242.801 |
| 18/02/2010 | 6,21 | 6,33 | 6,18 | 6,21 | -0,60% | 2,41% | 147.342 |
| 17/02/2010 | 5,99 | 6,33 | 5,95 | 6,25 | +4,37% | 6,25% | 238.366 |
| 16/02/2010 | 6,29 | 6,33 | 5,95 | 5,99 | -3,61% | 5,95% | 146.781 |
| 12/02/2010 | 6,21 | 6,40 | 6,14 | 6,21 | +0,00% | 4,22% | 73.043 |
| 11/02/2010 | 5,99 | 6,33 | 5,99 | 6,21 | +3,75% | 5,62% | 116.378 |
| 10/02/2010 | 6,18 | 6,36 | 5,95 | 5,99 | -3,61% | 6,67% | 98.638 |
| 09/02/2010 | 5,95 | 6,33 | 5,95 | 6,21 | +5,73% | 6,29% | 171.254 |
| 08/02/2010 | 6,14 | 6,21 | 5,80 | 5,88 | -4,27% | 6,71% | 296.555 |
| 05/02/2010 | 6,21 | 6,51 | 6,06 | 6,14 | -1,20% | 7,23% | 93.749 |
| 04/02/2010 | 6,55 | 6,55 | 6,18 | 6,21 | -4,60% | 5,71% | 187.257 |
| 03/02/2010 | 6,63 | 6,70 | 6,48 | 6,51 | -1,70% | 3,39% | 197.116 |
| 02/02/2010 | 6,70 | 6,81 | 6,59 | 6,63 | -1,12% | 3,35% | 100.268 |
| 01/02/2010 | 6,66 | 6,81 | 6,63 | 6,70 | +1,13% | 2,81% | 62.223 |
| 29/01/2010 | 6,70 | 6,85 | 6,55 | 6,63 | +0,00% | 4,47% | 132.007 |
| 28/01/2010 | 6,70 | 6,85 | 6,55 | 6,63 | -0,56% | 4,47% | 118.889 |
| 27/01/2010 | 6,63 | 6,85 | 6,55 | 6,66 | +0,00% | 4,52% | 119.878 |
| 26/01/2010 | 6,89 | 6,92 | 6,63 | 6,66 | -3,78% | 4,35% | 188.032 |
| 25/01/2010 | 6,92 | 6,96 | 6,74 | 6,92 | +1,09% | 3,24% | 97.489 |
| 22/01/2010 | 6,92 | 7,11 | 6,85 | 6,85 | -1,08% | 3,78% | 145.125 |
| 21/01/2010 | 7,19 | 7,45 | 6,92 | 6,92 | -3,65% | 7,29% | 182.288 |
| 20/01/2010 | 7,26 | 7,45 | 7,11 | 7,19 | -2,04% | 4,64% | 81.780 |
| 19/01/2010 | 7,19 | 7,41 | 7,19 | 7,34 | +2,08% | 3,13% | 62.971 |
| 15/01/2010 | 7,52 | 7,67 | 7,11 | 7,19 | -4,00% | 7,46% | 560.623 |
| 14/01/2010 | 7,67 | 7,71 | 7,41 | 7,49 | -2,91% | 3,90% | 157.976 |